Anzeige
❌
Mehr »
Dienstag, 20.10.2026 - Börsentäglich über 12.000 News
Lithium vor 2022. Kernkraft vor dem Comeback. Tiefseebergbau jetzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
KY

WKN: A3C5GK | ISIN: US50155Q1004 | Ticker-Symbol: 7XU
Tradegate
20.10.26 | 20:33
12,470 Euro
+5,32 % +0,630
1-Jahres-Chart
KYNDRYL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
KYNDRYL HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
12,41512,48020:35
12,42512,46520:35
PR Newswire
410 Leser
Artikel bewerten:
(2)

Kyndryl completes acquisition of Healthcare IT Leaders, LLC

Acquisition to accelerate AI-led modernization for healthcare providers and payors

NEW YORK, Sept. 14, 2026 /PRNewswire/ -- Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today announced it has completed its acquisition of Healthcare IT Leaders, LLC, an enterprise IT services provider serving hospitals and health systems across the United States, for up to $350 million, including a contingent performance-based earnout. The transaction follows Kyndryl's announcement on August 10, 2026, of its intent to acquire the company.

The acquisition strengthens Kyndryl's ability to help healthcare providers and payors modernize mission-critical technology environments by combining Healthcare IT Leaders' healthcare consulting and application managed services expertise with Kyndryl's infrastructure and AI capabilities.

Together, Kyndryl and Healthcare IT Leaders offer capabilities across applications, infrastructure and consulting services, enabling healthcare organizations to work with a single provider across their technology environments. Building on Kyndryl's experience supporting large-scale, highly regulated healthcare IT environments, the addition of Healthcare IT Leaders deepens Kyndryl's healthcare expertise and strengthens its capabilities across clinical, operational and workforce systems modernization.

Revenues generated by Healthcare IT Leaders over the twelve-month period ending March 31, 2026, were approximately 1% of Kyndryl's revenue for fiscal year 2026. This transaction does not change Kyndryl's fiscal year 2027 outlook provided on August 5, 2026. The acquisition is consistent with Kyndryl's capital allocation priorities - maintaining financial flexibility, including to invest in strategic growth initiatives with strong liquidity and investment-grade ratings. To preserve this flexibility, Kyndryl has temporarily paused its share repurchase program and will update investors when it resumes.

About Healthcare IT Leaders, LLC
Healthcare IT Leaders is a national leader in enterprise IT consulting, managed services and workforce solutions, providing strategy and talent for healthcare transformation across clinical, business, and operational systems. Areas of focus and expertise include EHR, ERP, WFM, RCM, Digital Health, Cloud, and Data.

About Kyndryl
Kyndryl (NYSE: KD) is a leading provider of mission-critical enterprise technology services, offering advisory, implementation and managed service capabilities to thousands of customers in more than 60 countries. As the world's largest IT infrastructure services provider, the Company designs, builds, manages and modernizes the complex information systems that the world depends on every day. For more information, visit www.kyndryl.com.

Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements often contain words such as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "may," "objectives," "opportunity," "outlook," "plan," "position," "predict," "project," "seek," "should," "target," "will," "would" and other similar words or expressions or the negative thereof or other variations thereon. All statements other than statements of historical fact, including without limitation statements concerning Kyndryl's plans, objectives, goals, beliefs, business strategies, future events, business condition, results of operations, financial position, business outlook and business trends and other non-historical statements, are forward-looking statements. These statements do not guarantee future performance and speak only as of the date of this press release. Except as required by law, Kyndryl assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual outcomes or results may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties, including those described in the "Risk Factors" section of Kyndryl's most recent Annual Report on Form 10-K, and may be further updated from time to time in Kyndryl's subsequent filings with the Securities and Exchange Commission.

Kyndryl Press Contact
[email protected]

SOURCE Kyndryl

© 2026 PR Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.